» Articles » PMID: 22726459

Comparative Proteomic Profiles Indicating Genetic Factors May Involve in Hepatocellular Carcinoma Familial Aggregation

Overview
Journal Cancer Sci
Specialty Oncology
Date 2012 Jun 26
PMID 22726459
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Familial aggregation of hepatocellular carcinoma (HCC), the third leading cause of cancer death worldwide, has shown to be a common phenomenon. We investigated the association between the genetic background and HCC familial aggregation. Serum samples were collected from HCC family members and normal control family members for screening the differentially expressed protein peaks with the approach of surface-enhanced laser desorption ionization time-of-flight mass spectrometry. Potential genetically associated protein peaks were selected and further identified by matrix assisted laser desorption ionization-time of flight mass spectrometry. A panel of six protein peaks (m/z 6432.94, 8478.35, 9381.91, 17284.67, 17418.34, and 18111.04) were speculated to reflect the genetic susceptibility of HCC familial aggregation. Three of them (m/z 6432.94, 8478.35, and 9381.91) were selected to identify as the candidate proteins. Nine identified proteins, including mostly apolipoprotein family (ApoA1, ApoA2, ApoC3, ApoE) and serum amyloid A protein (SAA), were found overexpressed in the multiple HCC cases family members. The comparative proteomic profiles have suggested that genetic factors ought to be taken into account for familial aggregation of HCC.

Citing Articles

Quantitative proteomics assay reveals G protein-coupled receptor kinase 4-induced HepG2 cell growth inhibition.

Luo Y, Yang J, Wang Y Heliyon. 2024; 10(8):e29514.

PMID: 38638965 PMC: 11024620. DOI: 10.1016/j.heliyon.2024.e29514.


Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets.

He Z, Chen Q, He W, Cao J, Yao S, Huang Q Front Oncol. 2023; 13:1086604.

PMID: 36937389 PMC: 10017446. DOI: 10.3389/fonc.2023.1086604.


ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC.

Wang J, Man Q, Zhong N, Wang H, Zhang C, Li S Int J Mol Sci. 2022; 23(21).

PMID: 36361568 PMC: 9654972. DOI: 10.3390/ijms232112777.


Tracking the important role of in hepatocellular carcinoma by single-cell sequencing analysis.

Yan P, Zhou B, Ma Y, Wang A, Hu X, Luo Y Oncol Lett. 2020; 19(2):1478-1486.

PMID: 31966074 PMC: 6956120. DOI: 10.3892/ol.2019.11235.


Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.

Zhang T, Guo J, Gu J, Wang Z, Wang G, Li H Oncol Rep. 2018; 41(1):279-291.

PMID: 30542696 PMC: 6278419. DOI: 10.3892/or.2018.6840.


References
1.
Beasley R . Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988; 61(10):1942-56. DOI: 10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j. View

2.
Gomaa A, Khan S, Toledano M, Waked I, Taylor-Robinson S . Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008; 14(27):4300-8. PMC: 2731180. DOI: 10.3748/wjg.14.4300. View

3.
Yokoyama Y, Kuramitsu Y, Takashima M, Iizuka N, Terai S, Oka M . Protein level of apolipoprotein E increased in human hepatocellular carcinoma. Int J Oncol. 2006; 28(3):625-31. View

4.
Hassan M, Spitz M, Thomas M, Curley S, Patt Y, Vauthey J . The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol. 2008; 50(2):334-41. PMC: 2658718. DOI: 10.1016/j.jhep.2008.08.016. View

5.
Pan J, Sun L, Tao Y, Zhou Z, Du X, Peng L . ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer. J Transl Med. 2011; 9:211. PMC: 3254596. DOI: 10.1186/1479-5876-9-211. View